-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $87

Benzinga·02/06/2026 15:54:13
Listen to the news
Piper Sandler analyst Allison Bratzel maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price target from $77 to $87.